New nanoparticles can perform gene editing in the lungs, MIT News

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

Nanoparticles may correct genetic defects in cystic fibrosis lungs

Lung Cancer Detection via Inhalable Nanosensors, Paper-Based Urine Test

Human Applications of Genetic Engineering - GESDA Science Breakthrough Radar

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

New nanoparticles deliver gene-editing tech directly into the lungs

Revolutionizing CRISPR: Quantum Biology and AI Merge to Enhance Genome Editing

New nanoparticles can perform gene editing in the lungs

Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

Breakthrough gene silencing method slashes cholesterol for a year in mice, no DNA damage

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

New nanoparticles can perform gene editing in the lungs, MIT News